Concentrix financials
$24.88−2.24%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Nov 30 | FY24 Nov 30 | FY23 Nov 30 | FY22 Nov 30 | FY21 Nov 30 |
|---|---|---|---|---|---|
| Revenue | $9.83B | $9.62B | $7.11B | $6.32B | $5.59B |
| Gross profit | $3.44B | $3.45B | $2.58B | $2.26B | $1.97B |
| Gross margin | 35.0% | 35.9% | 36.2% | 35.7% | 35.3% |
| Operating income | -$918.2M | $596.4M | $661.3M | $640.2M | $572.4M |
| Net income | -$1.28B | $241.7M | $307.8M | $428.4M | $399.8M |
| Net margin | −13.1% | 2.5% | 4.3% | 6.8% | 7.2% |
| Diluted EPS | $-20.36 | $3.71 | $5.70 | $8.28 | $7.70 |
| EBITDA | $1.27B | $1.30B | $1.05B | $949.7M | $849.6M |
| Operating cash flow | $807.0M | $667.5M | $678.0M | $600.7M | $514.2M |
| Free cash flow | $572.5M | $428.7M | $497.5M | $460.7M | $365.1M |
| Diluted shares | 63.0M | 65.1M | 54.0M | 51.7M | 51.9M |
Balance sheet
| Period end | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 |
|---|---|---|---|---|---|
| Cash & equivalents | $327.3M | $240.6M | $295.3M | $145.4M | $182.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.64B | $4.74B | $4.94B | $2.22B | $802.0M |
| Total assets | $10.76B | $11.99B | $12.49B | $6.67B | $5.05B |
| Total liabilities | $8.02B | $7.95B | $8.35B | $3.97B | $2.43B |
| Shareholders' equity | $2.74B | $4.04B | $4.14B | $2.70B | $2.62B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology